Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.
Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check2 days agoChange DetectedNo additions or deletions are visible; the two screenshots show the same page content.SummaryDifference0.0%
- Check9 days agoChange DetectedA metadata revision updated from v3.4.1 to v3.4.2. This change does not affect the study content or how the page functions.SummaryDifference0.0%
- Check18 days agoChange DetectedA minor version update from v3.4.0 to v3.4.1 with no visible changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check32 days agoChange DetectedMinor UI and metadata updates were made, including adding a Show glossary option and updating QC-related labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) to Revision: v3.4.0. The previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the older revision (v3.3.4) appear to have been replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check39 days agoChange DetectedRevision: v3.3.4 was added as the current version, replacing the previous v3.3.3.SummaryDifference0.0%
- Check67 days agoChange DetectedA full Locations section was added, enumerating study sites across the United States, Canada, Europe, Australia, and other regions. This provides clear access to where the trial is being conducted.SummaryDifference4%
Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.